Compositions and methods for viral sensitization
US-2024360115-A1 · Oct 31, 2024 · US
US9255088B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9255088-B2 |
| Application number | US-201313764748-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 11, 2013 |
| Priority date | Aug 11, 2010 |
| Publication date | Feb 9, 2016 |
| Grant date | Feb 9, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Premature termination codons readthrough compounds, composition thereof, and methods of making and using the same are provided.
Opening claim text (preview).
We claim: 1. A compound having the ability to increase read through of premature termination codons (PTCs) in RNA, a pharmaceutically acceptable salt thereof, having a structure of formula (VIII): wherein: X is O; R 3 is an ortho, meta, or para group and is a hydrogen, halo, or nitro; and R 4 is hydrogen, —C(O)H, halo, or a C1-C6 group. 2. A compound having the ability to read through premature termination codons (PTCs) in RNA, a pharmaceutically acceptable salt thereof, having a structure of formula (IX): 3. The compound of claim 1 where the compound is selected from: 4. The compound of claim 1 , having one of the following formulas: 5. A composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. 6. A method of treating or ameliorating a medical condition associated with premature termination codons (PTCs) in RNA, comprising: administering to a subject a compound according to claim 1 , wherein the subject has an ATM gene that encodes one or more PTCs, or a DMD gene that encodes one or more PTCs.
having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
of the same non-condensed six-membered aromatic ring · CPC title
containing carbocyclic rings other than six-membered · CPC title
the carbon skeleton being further substituted by singly-bound oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.